NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
August 31, 2020

News of the first U.S. coronavirus case hit the American public on Tuesday, Jan. 21. For Jessilyn Dunn, PhD, assistant professor in the Departments of Biomedical Engineering and Biostatistics and Bioinformatics at Duke University and director of the Duke BIG IDEAs Lab, the infection in Washington State was a cue to launch a new study—CovIdentify.
August 28, 2020

RTP's APIE Therapeutics has signed a licensing agreement with RTI International to develop a class of RTI-developed compounds targeting heart failure and lung disease.
August 24, 2020

Durham based BioAgilytix Labs has partnered with Boston’s Brio Systems to launch a platform to provide U.S. employers comprehensive COVID-19 testing programs.
August 24, 2020

Durham's Pairwise uses its gene editing technology to harness nutrient-rich, pest-resistant qualities of the leafy green Brassica juncea while diminishing pungent flavor.
August 20, 2020

Durham's IMMvention Therapeutix, which discovers and develops therapies that inhibit inflammation, was one of three finalists in LaunchBio’s Big Pitch competition for the most promising life science or biotech startup in the United States.
August 20, 2020

Durham-based Dualogics has sold its core technology for producing therapeutic antibodies to a Canadian biotechnology company.
August 20, 2020

Merz Therapeutics, with North American headquarters in Raleigh, has gained a new use for Xeomin, its botulinum toxin therapy.
August 19, 2020

Leading life sciences magazine PharmaVoice has named three North Carolina executives to its list of the 100 most inspiring leaders in the pharmaceutical industry.
August 18, 2020

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reached an important regulatory milestone for its potential therapy for small cell lung cancer.
August 14, 2020

T-Line Hernia Mesh, the newest medical advance from Deep Blue Medial Advances, has just received U.S. Food and Drug Administration marketing clearance.
August 13, 2020

UPL, a multinational agriculture company based in India, has opened a global research-and-development hub in Research Triangle Park to develop products for sustainable agriculture in partnership with collaborating companies.
August 13, 2020

Eva Garland Consulting, LLC (EGC) is one of the country’s fastest-growing private businesses – for a third year in a row – as other NC life sciences companies also made the list, according to Inc. magazine.
August 12, 2020

Federal health officials have tapped RTI International to join a collaboration tracking COVID-19’s ability to cause severe illness and the effectiveness of proposed treatments.
August 11, 2020

A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell therapy startups with plans to build an $83 million biomanufacturing facility in Durham that could employ more than 200 people over five years.
August 4, 2020

The Dole Food Company has entered a five-year strategic partnership with the young RTP-based ag tech company Elo Life Systems to keep bananas alive and available, because Elo's gene editing technology is uniquely qualified to develop Fusarium-resistant banana varieties.